Cargando…
Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
Autores principales: | Schmaier, Alec A., Bhatt, Deepak L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015345/ https://www.ncbi.nlm.nih.gov/pubmed/29858359 http://dx.doi.org/10.1161/JAHA.118.009564 |
Ejemplares similares
-
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021) -
Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post‐Thrombolysis: Findings From Get With The Guidelines‐Stroke
por: Masrur, Shihab, et al.
Publicado: (2015) -
The Worthing Experiment
Publicado: (1958) -
Worth Attention
Publicado: (1885) -
Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
por: Idicula, Titto T, et al.
Publicado: (2010)